Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jan;40(1):122–126. doi: 10.1128/aac.40.1.122

Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

M M París 1, S Shelton 1, M Trujillo 1, S M Hickey 1, G H McCracken Jr 1
PMCID: PMC163069  PMID: 8787892

Abstract

Although penicillin resistance among Streptococcus pneumoniae strains is increasing in many areas, resistance to clindamycin remains low. In our well-characterized rabbit meningitis model, we conducted experiments to evaluate the bacteriologic efficacy of clindamycin after a penicillin- and cephalosporin-resistant S. pneumoniae strain was intracisternally inoculated. Animals received a loading intravenous dose of 30 mg of clindamycin per kg of body weight and then two doses of 20 mg/kg given 5 h apart. In addition to clindamycin, some animals received dexamethasone (DXM) with or without ceftriaxone. The concentrations of clindamycin in cerebrospinal fluid were from 8.9 to 12.8% of the concomitant concentrations in serum and were unaffected by DXM administration. Mean changes in CFU (log10 per milliliter) at 10 and 24 h were -3.7 and -6.1, respectively, for clindamycin-treated rabbits, -3.6 and -6.3 for clindamycin-DXM-treated rabbits, -3.9 and -5.8, respectively, for clindamycin-ceftriaxone-treated rabbits, and -5.0 and -6.7, respectively, for clindamycin-ceftriaxone-DXM-treated rabbits. By 24 h all but one of the cultures of cerebrospinal fluid (that from a clindamycin-DXM-treated rabbit) were sterile. Because of the potential risk for clindamycin-treated rabbits to develop macrolide-lincosamide resistance, we attempted, unsuccessfully, to induce clindamycin resistance in vitro in two S. pneumoniae strains. Although clindamycin therapy might be effective in selected patients with multiple-drug-resistant pneumococcal meningitis who have failed conventional treatments, clinical experience is necessary before it can be recommended.

Full Text

The Full Text of this article is available as a PDF (222.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso J., Madrigal V., García-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr Infect Dis J. 1991 Mar;10(3):256–256. doi: 10.1097/00006454-199103000-00022. [DOI] [PubMed] [Google Scholar]
  2. Asensi F., Otero M. C., Pérez-Tamarit D., Rodríguez-Escribano I., Cabedo J. L., Gresa S., Cantón E. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. J Chemother. 1993 Apr;5(2):133–134. doi: 10.1080/1120009x.1993.11739221. [DOI] [PubMed] [Google Scholar]
  3. Asensi F., Pérez-Tamarit D., Otero M. C., Gallego M., Llanes S., Abadia C., Cantó E. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr Infect Dis J. 1989 Dec;8(12):895–895. doi: 10.1097/00006454-198912000-00019. [DOI] [PubMed] [Google Scholar]
  4. Bradley J. S., Connor J. D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 1991 Nov;10(11):871–873. [PubMed] [Google Scholar]
  5. Catalán M. J., Fernández J. M., Vazquez A., Varela de Seijas E., Suárez A., Bernaldo de Quirós J. C. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis. 1994 May;18(5):766–769. doi: 10.1093/clinids/18.5.766. [DOI] [PubMed] [Google Scholar]
  6. Courvalin P., Carlier C. Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol Gen Genet. 1986 Nov;205(2):291–297. doi: 10.1007/BF00430441. [DOI] [PubMed] [Google Scholar]
  7. Dacey R. G., Sande M. A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother. 1974 Oct;6(4):437–441. doi: 10.1128/aac.6.4.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dannemann B. R., Israelski D. M., Remington J. S. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med. 1988 Nov;148(11):2477–2482. [PubMed] [Google Scholar]
  9. Dannemann B., McCutchan J. A., Israelski D., Antoniskis D., Leport C., Luft B., Nussbaum J., Clumeck N., Morlat P., Chiu J. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992 Jan 1;116(1):33–43. doi: 10.7326/0003-4819-116-1-33. [DOI] [PubMed] [Google Scholar]
  10. Dhawan V. K., Thadepalli H. Clindamycin: a review of fifteen years of experience. Rev Infect Dis. 1982 Nov-Dec;4(6):1133–1153. doi: 10.1093/clinids/4.6.1133. [DOI] [PubMed] [Google Scholar]
  11. Doern G. V. Resistance among problem respiratory pathogens in pediatrics. Pediatr Infect Dis J. 1995 May;14(5):420–423. doi: 10.1097/00006454-199505001-00003. [DOI] [PubMed] [Google Scholar]
  12. Engel H. W., Soedirman N., Rost J. A., van Leeuwen W. J., van Embden J. D. Transferability of macrolide, lincomycin, and streptogramin resistances between group A, B, and D streptococci, Streptococcus pneumoniae, and Staphylococcus aureus. J Bacteriol. 1980 May;142(2):407–413. doi: 10.1128/jb.142.2.407-413.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feldman W. E. Bacteroides fragilis ventriculitis and meningitis. Report of two cases. Am J Dis Child. 1976 Aug;130(8):880–883. doi: 10.1001/archpedi.1976.02120090090017. [DOI] [PubMed] [Google Scholar]
  14. Fernandes P. B., Baker W. R., Freiberg L. A., Hardy D. J., McDonald E. J. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. Antimicrob Agents Chemother. 1989 Jan;33(1):78–81. doi: 10.1128/aac.33.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Friedland I. R., Klugman K. P. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child. 1992 Aug;146(8):920–923. doi: 10.1001/archpedi.1992.02160200042023. [DOI] [PubMed] [Google Scholar]
  16. Friedland I. R., McCracken G. H., Jr Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994 Aug 11;331(6):377–382. doi: 10.1056/NEJM199408113310607. [DOI] [PubMed] [Google Scholar]
  17. Friedland I. R., Shelton S., Paris M., Rinderknecht S., Ehrett S., Krisher K., McCracken G. H., Jr Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993 Mar;12(3):196–200. doi: 10.1097/00006454-199303000-00004. [DOI] [PubMed] [Google Scholar]
  18. Jafari H. S., Sáez-Llorens X., Ramilo O., Shelton S. L., McCracken G. H., Jr Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Antimicrob Agents Chemother. 1991 Feb;35(2):220–223. doi: 10.1128/aac.35.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. John C. C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994 Feb;18(2):188–193. doi: 10.1093/clinids/18.2.188. [DOI] [PubMed] [Google Scholar]
  20. Khuri-Bulos N., McIntosh K., Ehret J. Bacteroides brain abscess treated with clindamycin. Am J Dis Child. 1973 Jul;126(1):96–98. doi: 10.1001/archpedi.1973.02110190084018. [DOI] [PubMed] [Google Scholar]
  21. Kleiman M. D., Weinberg G. A., Reynolds J. K., Allen S. D. Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr Infect Dis J. 1993 Sep;12(9):782–784. doi: 10.1097/00006454-199309000-00019. [DOI] [PubMed] [Google Scholar]
  22. Leggiadro R. J., Barrett F. F., Chesney P. J., Davis Y., Tenover F. C. Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-south children's hospital. Pediatr Infect Dis J. 1994 Apr;13(4):320–322. [PubMed] [Google Scholar]
  23. Leport C., Bastuji-Garin S., Perronne C., Salmon D., Marche C., Briçaire F., Vilde J. L. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. J Infect Dis. 1989 Sep;160(3):557–558. doi: 10.1093/infdis/160.3.557. [DOI] [PubMed] [Google Scholar]
  24. Mason E. O., Jr, Kaplan S. L., Lamberth L. B., Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug;36(8):1703–1707. doi: 10.1128/aac.36.8.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murphy T. V., McCracken G. H., Jr, Zweighaft T. C., Hansen E. J. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr. 1981 Sep;99(3):406–409. doi: 10.1016/s0022-3476(81)80328-9. [DOI] [PubMed] [Google Scholar]
  26. Mustafa M. M., Ramilo O., Mertsola J., Risser R. C., Beutler B., Hansen E. J., McCracken G. H., Jr Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis. 1989 Nov;160(5):818–825. doi: 10.1093/infdis/160.5.818. [DOI] [PubMed] [Google Scholar]
  27. París M. M., Hickey S. M., Trujillo M., Shelton S., McCracken G. H., Jr Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1995 Jun;39(6):1243–1246. doi: 10.1128/aac.39.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. París M. M., Hickey S. M., Uscher M. I., Shelton S., Olsen K. D., McCracken G. H., Jr Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1994 Jun;38(6):1320–1324. doi: 10.1128/aac.38.6.1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. París M. M., Ramilo O., McCracken G. H., Jr Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1995 Oct;39(10):2171–2175. doi: 10.1128/aac.39.10.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Picardi J. L., Lewis H. P., Tan J. S., Phair J. P. Clindamycin concentrations in the central nervous system of primates before and after head trauma. J Neurosurg. 1975 Dec;43(6):717–720. doi: 10.3171/jns.1975.43.6.0717. [DOI] [PubMed] [Google Scholar]
  31. Pikis A., Akram S., Donkersloot J. A., Campos J. M., Rodriguez W. J. Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area. Arch Pediatr Adolesc Med. 1995 Jan;149(1):30–35. doi: 10.1001/archpedi.1995.02170130032007. [DOI] [PubMed] [Google Scholar]
  32. Rolston K. V., Hoy J. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Am J Med. 1987 Sep;83(3):551–554. doi: 10.1016/0002-9343(87)90769-8. [DOI] [PubMed] [Google Scholar]
  33. Saunders C. W., Guild W. R. Properties and transforming activities of two plasmids in Streptococcus pneumoniae. Mol Gen Genet. 1980;180(3):573–578. doi: 10.1007/BF00268062. [DOI] [PubMed] [Google Scholar]
  34. Simon H. J., Yin E. J. Microbioassay of antimicrobial agents. Appl Microbiol. 1970 Apr;19(4):573–579. doi: 10.1128/am.19.4.573-579.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sloas M. M., Barrett F. F., Chesney P. J., English B. K., Hill B. C., Tenover F. C., Leggiadro R. J. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992 Aug;11(8):662–666. [PubMed] [Google Scholar]
  36. Syrogiannopoulos G. A., Hansen E. J., Erwin A. L., Munford R. S., Rutledge J., Reisch J. S., McCracken G. H., Jr Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis. 1988 Feb;157(2):237–244. doi: 10.1093/infdis/157.2.237. [DOI] [PubMed] [Google Scholar]
  37. Welby P. L., Keller D. S., Cromien J. L., Tebas P., Storch G. A. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J. 1994 Apr;13(4):281–287. doi: 10.1097/00006454-199404000-00007. [DOI] [PubMed] [Google Scholar]
  38. Westblom T. U., Belshe R. B. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient. Scand J Infect Dis. 1988;20(5):561–563. doi: 10.3109/00365548809032507. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES